Universal Infant Immunisation Against Respiratory Syncytial Virus and European Inequalities: The Pandemics Lesson Has Not Been Learnt
- Daniele De Luca; Manuel Sanchez-Luna; Karl Schettler; Louis Bont; Eugenio Baraldi
Access Resources
About
This comment discusses the challenges of implementing universal infant immunization against respiratory syncytial virus (RSV) in Europe. RSV is a major cause of illness in infants, leading to hospital stays and high costs. New vaccines and treatments are available, but their rollout is slow due to regional healthcare systems, bureaucratic delays, and cost concerns. This uneven progress creates health disparities across countries. The article stresses the need for faster action to protect infants' health and ensure enough hospital resources during RSV season while learning from past pandemics' lessons on urgent public health responses.
Tags
More like this
The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.